SPIMACO completes full acquisition of Dammam Pharma
Argaam17/12/2023
SPIMACO’s subsidiary seals deal with Merck to manufacture type 2 diabetes meds in KSA
Argaam19/11/2023
SPIMACO approves Dammam Pharma's 50% capital hike
Argaam27/12/2018
Argaam17/12/2023
Argaam19/11/2023
Argaam27/12/2018
Argaam17/12/2023
Argaam19/11/2023
Argaam27/12/2018
